These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 23938262)

  • 41. Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls.
    Hu Z; Dong J; Wang LE; Ma H; Liu J; Zhao Y; Tang J; Chen X; Dai J; Wei Q; Zhang C; Shen H
    Carcinogenesis; 2012 Apr; 33(4):828-34. PubMed ID: 22298638
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's Diseases.
    Batistela MS; Josviak ND; Sulzbach CD; de Souza RL
    Int J Neurosci; 2017 Jun; 127(6):547-558. PubMed ID: 27381850
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.
    Hall S; Öhrfelt A; Constantinescu R; Andreasson U; Surova Y; Bostrom F; Nilsson C; Håkan W; Decraemer H; Någga K; Minthon L; Londos E; Vanmechelen E; Holmberg B; Zetterberg H; Blennow K; Hansson O
    Arch Neurol; 2012 Nov; 69(11):1445-52. PubMed ID: 22925882
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Altered Expression Levels of MicroRNA-132 and Nurr1 in Peripheral Blood of Parkinson's Disease: Potential Disease Biomarkers.
    Yang Z; Li T; Li S; Wei M; Qi H; Shen B; Chang RC; Le W; Piao F
    ACS Chem Neurosci; 2019 May; 10(5):2243-2249. PubMed ID: 30817108
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus.
    Wang H; Peng W; Ouyang X; Li W; Dai Y
    Transl Res; 2012 Sep; 160(3):198-206. PubMed ID: 22683424
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma near-infrared spectroscopy for diagnosis of idiopathic Parkinson's disease: the SPIN-PD study.
    Ravina B; Eberly S; Oakes D; Lang AE; Dodelet V; Roos P; Harman J; Shoulson I; Schipper HM
    Biomark Med; 2015; 9(2):89-97. PubMed ID: 25689898
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma viral microRNA profiles reveal potential biomarkers for chronic active Epstein-Barr virus infection.
    Kawano Y; Iwata S; Kawada J; Gotoh K; Suzuki M; Torii Y; Kojima S; Kimura H; Ito Y
    J Infect Dis; 2013 Sep; 208(5):771-9. PubMed ID: 23687223
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating microRNAs as candidate markers to distinguish heart failure in breathless patients.
    Ellis KL; Cameron VA; Troughton RW; Frampton CM; Ellmers LJ; Richards AM
    Eur J Heart Fail; 2013 Oct; 15(10):1138-47. PubMed ID: 23696613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients.
    Kumar S; Keerthana R; Pazhanimuthu A; Perumal P
    Indian J Biochem Biophys; 2013 Jun; 50(3):210-4. PubMed ID: 23898484
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis.
    Lewitt PA; Li J; Lu M; Beach TG; Adler CH; Guo L;
    Mov Disord; 2013 Oct; 28(12):1653-60. PubMed ID: 23873789
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.
    Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ
    Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease.
    El-Agnaf OM; Salem SA; Paleologou KE; Curran MD; Gibson MJ; Court JA; Schlossmacher MG; Allsop D
    FASEB J; 2006 Mar; 20(3):419-25. PubMed ID: 16507759
    [TBL] [Abstract][Full Text] [Related]  

  • 53. miRNA expression is highly sensitive to a drug therapy in Parkinson's disease.
    Alieva AKh; Filatova EV; Karabanov AV; Illarioshkin SN; Limborska SA; Shadrina MI; Slominsky PA
    Parkinsonism Relat Disord; 2015 Jan; 21(1):72-4. PubMed ID: 25465742
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MiRNA-199a-3p: A potential circulating diagnostic biomarker for early gastric cancer.
    Li C; Li JF; Cai Q; Qiu QQ; Yan M; Liu BY; Zhu ZG
    J Surg Oncol; 2013 Aug; 108(2):89-92. PubMed ID: 23733518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA-150 serves as a diagnostic biomarker and is involved in the inflammatory pathogenesis of Parkinson's disease.
    Li H; Yu L; Li M; Chen X; Tian Q; Jiang Y; Li N
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1189. PubMed ID: 32077254
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function.
    Miñones-Moyano E; Porta S; Escaramís G; Rabionet R; Iraola S; Kagerbauer B; Espinosa-Parrilla Y; Ferrer I; Estivill X; Martí E
    Hum Mol Genet; 2011 Aug; 20(15):3067-78. PubMed ID: 21558425
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exosomal microRNAs in Parkinson's disease: insights into biomarker potential and disease pathology.
    Chandran D; Krishnan S; Urulangodi M; Gopala S
    Neurol Sci; 2024 Aug; 45(8):3625-3639. PubMed ID: 38532190
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myocardial and circulating levels of microRNA-21 reflect left ventricular fibrosis in aortic stenosis patients.
    Villar AV; García R; Merino D; Llano M; Cobo M; Montalvo C; Martín-Durán R; Hurlé MA; Nistal JF
    Int J Cardiol; 2013 Sep; 167(6):2875-81. PubMed ID: 22882958
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miRNAs as novel therapeutic targets and diagnostic biomarkers for Parkinson's disease: a patent evaluation of WO2014018650.
    Hesse M; Arenz C
    Expert Opin Ther Pat; 2014 Nov; 24(11):1271-6. PubMed ID: 25307171
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum microRNA-133b is associated with low ceruloplasmin levels in Parkinson's disease.
    Zhao N; Jin L; Fei G; Zheng Z; Zhong C
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1177-80. PubMed ID: 25218846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.